Title(s):
Professor of Medicine
Professor of Oncology
Professor of Oncology
Appointment Phone:
410-955-9270
Primary Location:
Johns Hopkins Outpatient Center
Expertise:
Endocrine Diseases, Endocrinology, Thyroid Cancer, Thyroid Disorders, Thyroid Nodules
Education and Experience
Training
- Second Military Medical University (Shanghai 200433 )/ (1984)
Residencies
- Greater Baltimore Medical Center (Baltimore MD)/ Internal Medicine (2000)
Fellowships
- Johns Hopkins University School of Medicine (Baltimore MD)/ EndocrinologyMetabolism (2003)
- University of California San Diego School of Medicine (La Jolla CA)/ Pharmacology (1997)
Certifications
- Internal Medicine, American Board of Internal Medicine (2010)
- Endocrinology/Diabetes/Metabolism, American Board of Internal Medicine (2003)
Locations
Johns Hopkins Outpatient Center
601 N. Caroline Street
Baltimore, MD 21287
Phone: 410-502-4926
Appointment Phone: 410-955-9270
Location Map
The Johns Hopkins Hospital
600 N. Wolfe Street
1830 East Monument Street Room Suite 333
Baltimore, MD 21287
Phone: 410-502-4926
Appointment Phone: 410-955-9270
Location Map
Department / Division
-
Medicine - Endocrinology and Metabolism
Centers/Institutes
Centers / Institutes
- Thyroid Cancer Center
- Thyroid Tumor Center
Bio
Expertise
- Endocrine Diseases
- Endocrinology
- Thyroid Cancer
- Thyroid Disorders
- Thyroid Nodules
Research
Research and Publications
Hu, S.; Ewertz, M.; Tufano, R.P.; Brait, M.; Carvalho, A.L.; Liu, D.; Tufaro, A.P.; Basaria, S.; Cooper, D.S.; Sidransky, D.; Ladenson, P.W.; Xing, M. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab. 2006 Jan;91(1):98-104.
Hu, S.; Liu, D.; Tufano, R.P.; Carson, K.A.; Rosenbaum, E.; Cohen, Y.; Holt, E.H.; Kiseljak-Vassiliades, K.; Rhoden, K.J.; Tolaney, S.; Condouris, S.; Tallini, G.; Westra, W.H.; Umbricht, C.B.; Zeiger, M.A.; Califano, J.A.; Vasko, V.; Xing, M. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer. 2006 Nov 15;119(10):2322-2329.
Ball, D.W.; Jin, N.; Rosen, D.M.; Dackiw, A.; Sidransky, D.; Xing, M.; Nelkin, B.D. Selective Growth Inhibition in BRAF Mutant Thyroid Cancer by the Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244. J Clin Endocrinol Metab. 2007 Dec;92(12):4712-4718.
Hu, S.; Liu, D.; Tufano, R.P.; Carson, K.A.; Rosenbaum, E.; Cohen, Y.; Holt, E.H.; Kiseljak-Vassiliades, K.; Rhoden, K.J.; Tolaney, S.; Condouris, S.; Tallini, G.; Westra, W.H.; Umbricht, C.B.; Zeiger, M.A.; Califano, J.A.; Vasko, V.; Xing, M. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer. 2006 Nov 15;119(10):2322-2329.
Ball, D.W.; Jin, N.; Rosen, D.M.; Dackiw, A.; Sidransky, D.; Xing, M.; Nelkin, B.D. Selective Growth Inhibition in BRAF Mutant Thyroid Cancer by the Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244. J Clin Endocrinol Metab. 2007 Dec;92(12):4712-4718.
Research Interests
- Thyroid Cancer and Thyroid Nodules
More Info
Languages
- English
- Chinese
Clinical Trials
- Thyroid Cancer, novel therapeutic agents, diagnostic and prognostic molecular markers
Additional Resources
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts